Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer

Wu,Qiongwei; Zhang,Wenying; Liu,Yu; Huang,Yuhua; Wu,Huiheng; Ma,Chengbin

doi:10.3892/ol.2021.12982

Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer

Authors:
- Qiongwei Wu
- Wenying Zhang
- Yu Liu
- Yuhua Huang
- Huiheng Wu
- Chengbin Ma
View Affiliations

Affiliations: Gynecology Department, Shanghai Changning Maternity and Infant Health Hospital, Shanghai 200051, P.R. China
Published online on: August 10, 2021 https://doi.org/10.3892/ol.2021.12982
Article Number: 721
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The deregulation of histone deacetylase 1 (HDAC1) is reportedly involved in the progression of several cancer types. However, its function in endometrial cancer remains unknown. The aim of the present study was to clarify the role of HDAC1 in aerobic glycolysis and the progression of endometrial cancer. Lentiviral vector transfection was used to up‑ and downregulate HDAC1 expression in HEC‑1‑A endometrial cancer cells. The effects of HDAC1 on cellular proliferation, apoptosis, migration, invasiveness and tumorigenesis were determined by CCK‑8, flow cytometry, wound‑healing, transwell chamber and in vivo tumor formation experiments, respectively. HDAC1 level was significantly increased in endometrial cancer tissues and cells, and its high expression was associated with advanced clinicopathological progression. HEC‑1‑A cell proliferation, invasiveness, migration and tumorigenesis were enhanced, and apoptosis was inhibited when HDAC1 was overexpressed. Moreover, upregulation of HDAC1 significantly promoted the epithelial‑mesenchymal transition of HEC‑1‑A cells, and increased glucose consumption, lactate secretion and ATP levels. Collectively, the present study revealed that HDAC1 promoted the aerobic glycolysis and progression of endometrial cancer, which may provide a potential target for endometrial cancer treatment.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
2	Morice P, Leary A, Creutzberg C, Abu-Rustum N and Darai E: Endometrial cancer. Lancet. 387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
3	Ma J, Li D, Kong FF, Yang D, Yang H and Ma XX: miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development. J Exp Clin Cancer Res. 37:192018. View Article : Google Scholar : PubMed/NCBI
4	Chen G, Zhang Y, Liang J, Li W, Zhu Y, Zhang M, Wang C and Hou J: Deregulation of hexokinase II is associated with glycolysis, autophagy, and the epithelial-mesenchymal transition in tongue squamous cell carcinoma under hypoxia. Biomed Res Int. 2018:84807622018.PubMed/NCBI
5	Chen G, Liu H, Zhang Y, Liang J, Zhu Y, Zhang M, Yu D, Wang C and Hou J: Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma. Exp Cell Res. 370:46–57. 2018. View Article : Google Scholar : PubMed/NCBI
6	Lee M and Yoon JH: Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication. World J Biol Chem. 6:148–161. 2015. View Article : Google Scholar : PubMed/NCBI
7	Han J, Zhang L, Guo H, Wysham WZ, Roque DR, Willson AK, Sheng X, Zhou C and Bae-Jump VL: Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol. 138:668–675. 2015. View Article : Google Scholar : PubMed/NCBI
8	Han X, Ren C, Yang T, Qiao P, Wang L, Jiang A, Meng Y, Liu Z, Du Y and Yu Z: Negative regulation of AMPKalpha1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer. Oncogene. 38:6537–6549. 2019. View Article : Google Scholar : PubMed/NCBI
9	Ganapathy-Kanniappan S: Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype. Crit Rev Biochemi Mol Biol. 53:667–682. 2018. View Article : Google Scholar : PubMed/NCBI
10	Mackay HJ, Eisenhauer EA, Kamel-Reid S, Tsao M, Clarke B, Karakasis K, Werner HM, Trovik J, Akslen LA, Salvesen HB, et al: Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. Cancer. 120:603–610. 2014. View Article : Google Scholar : PubMed/NCBI
11	Gehrig PA, Le LV, Olatidoye B and Geradts J: Estrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma. Cancer. 86:2083–2089. 1999. View Article : Google Scholar : PubMed/NCBI
12	Myers AP: New strategies in endometrial cancer: Targeting the PI3K/mTOR pathway-the devil is in the details. Clin Cancer Res. 19:5264–5274. 2013. View Article : Google Scholar : PubMed/NCBI
13	Li LH, Zhang PR, Cai PY and Li ZC: Histone deacetylase inhibitor, romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway. Biomed Pharmacother. 82:161–166. 2016. View Article : Google Scholar : PubMed/NCBI
14	De U, Son JY, Sachan R, Park YJ, Kang D, Yoon K, Lee BM, Kim IS, Moon HR and Kim HS: A new synthetic histone deacetylase inhibitor, MHY2256, induces apoptosis and autophagy cell death in endometrial cancer cells via p53 acetylation. Int J Mol Sci. 19:27432018. View Article : Google Scholar : PubMed/NCBI
15	Zheng Y and Yang X, Wang C, Zhang S, Wang Z, Li M, Wang Y, Wang X and Yang X: HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway. Sci Rep. 10:35762020. View Article : Google Scholar : PubMed/NCBI
16	Weichert W: HDAC expression and clinical prognosis in human malignancies. Cancer Lett. 280:168–176. 2009. View Article : Google Scholar : PubMed/NCBI
17	Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, Bernard L, Draetta GF, Alcalay M, Seiser C and Chiocca S: Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol. 27:4784–4795. 2007. View Article : Google Scholar : PubMed/NCBI
18	Tang Z, Ding S, Huang H, Luo P, Qing B, Zhang S and Tang R: HDAC1 triggers the proliferation and migration of breast cancer cells via upregulation of interleukin-8. Biol Chem. 398:1347–1356. 2017. View Article : Google Scholar : PubMed/NCBI
19	Cao LL, Song X, Pei L, Liu L, Wang H and Jia M: Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis. Medicine (Baltimore). 96:e76632017. View Article : Google Scholar : PubMed/NCBI
20	Liu X, Yu Y, Zhang J, Lu C, Wang L, Liu P and Song H: HDAC1 silencing in ovarian cancer enhances the chemotherapy response. Cell Physiol Biochem. 48:1505–1518. 2018. View Article : Google Scholar : PubMed/NCBI
21	Cao LL, Yue Z, Liu L, Pei L, Yin Y, Qin L, Zhao J, Liu H, Wang H and Jia M: The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy. Oncotarget. 8:39241–39253. 2017. View Article : Google Scholar : PubMed/NCBI
22	Weichert W, Roske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T and Denkert C: Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: Specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res. 14:1669–1677. 2008. View Article : Google Scholar : PubMed/NCBI
23	Prat J: FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 104:177–178. 2009. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S, Li Y, You W, Dong Q, Hong T, et al: Transcriptional regulation of the Warburg effect in cancer by SIX1. Cancer Cell. 33:368–385. 2018. View Article : Google Scholar : PubMed/NCBI
26	Liu F, Gu LN, Shan BE, Geng CZ and Sang MX: Biomarkers for EMT and MET in breast cancer: An update. Oncol Lett. 12:4869–4876. 2016. View Article : Google Scholar : PubMed/NCBI
27	Nantajit D, Lin D and Li JJ: The network of epithelial-mesenchymal transition: Potential new targets for tumor resistance. J Cancer Res Clin Oncol. 141:1697–1713. 2015. View Article : Google Scholar : PubMed/NCBI
28	Yang XJ and Seto E: HATs and HDACs: From structure, function and regulation to novel strategies for therapy and prevention. Oncogene. 26:5310–5318. 2007. View Article : Google Scholar : PubMed/NCBI
29	Villagra A, Sotomayor EM and Seto E: Histone deacetylases and the immunological network: Implications in cancer and inflammation. Oncogene. 29:157–173. 2010. View Article : Google Scholar : PubMed/NCBI
30	Glozak MA and Seto E: Histone deacetylases and cancer. Oncogene. 26:5420–5432. 2007. View Article : Google Scholar : PubMed/NCBI
31	Stazi G, Fioravanti R, Mai A, Mattevi A and Valente S: Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer. Curr Opin Chem Biol. 50:89–100. 2019. View Article : Google Scholar : PubMed/NCBI
32	Garmpis N, Damaskos C, Garmpi A, Spartalis E, Kalampokas E, Kalampokas T, Margonis GA, Schizas D, Andreatos N, Angelou A, et al: Targeting histone deacetylases in endometrial cancer: A paradigm-shifting therapeutic strategy? Eur Rev Med Pharmacol Sci. 22:950–960. 2018.PubMed/NCBI
33	Khabele D, Son DS, Parl AK, Goldberg GL, Augenlicht LH, Mariadason JM and Rice VM: Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: Implications for therapy. Cancer Biol Ther. 6:795–801. 2007. View Article : Google Scholar : PubMed/NCBI
34	Lin CL, Tsai ML, Lin CY, Hsu KW, Hsieh WS, Chi WM, Huang LC and Lee CH: HDAC1 and HDAC2 double knockout triggers cell apoptosis in advanced thyroid cancer. Int J Mol Sci. 20:4542019. View Article : Google Scholar : PubMed/NCBI
35	Zhang L, Bu L, Hu J, Xu Z, Ruan L, Fang Y and Wang P: HDAC1 knockdown inhibits invasion and induces apoptosis in non-small cell lung cancer cells. Biol Chem. 399:603–610. 2018. View Article : Google Scholar : PubMed/NCBI
36	Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee SJ, Kim DS and Park SM: HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. Oncol Rep. 33:2299–2308. 2015. View Article : Google Scholar : PubMed/NCBI
37	Feng J, Cen J, Li J, Zhao R, Zhu C, Wang Z, Xie J and Tang W: Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of snail. Cell Adh Migr. 9:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
38	Jakobsen KR, Demuth C, Sorensen BS and Nielsen AL: The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Transl Lung Cancer Res. 5:172–182. 2016. View Article : Google Scholar : PubMed/NCBI
39	Sakamoto T, Kobayashi S, Yamada D, Nagano H, Tomokuni A, Tomimaru Y, Noda T, Gotoh K, Asaoka T, Wada H, et al: A histone deacetylase inhibitor suppresses epithelial-mesenchymal transition and attenuates chemoresistance in biliary tract cancer. PLoS One. 11:e01459852016. View Article : Google Scholar : PubMed/NCBI
40	Ruscetti M, Dadashian EL, Guo W, Quach B, Mulholland DJ, Park JW, Tran LM, Kobayashi N, Bianchi-Frias D, Xing Y, et al: HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene. 35:3781–3795. 2016. View Article : Google Scholar : PubMed/NCBI
41	Bruzzese F, Leone A, Rocco M, Carbone C, Piro G, Caraglia M, Gennaro ED and Budillon A: HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. J Cell Physiol. 226:2378–2390. 2011. View Article : Google Scholar : PubMed/NCBI
42	Lunt SY and Heiden MG: Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Ann Rev Cell Dev Biol. 27:441–464. 2011. View Article : Google Scholar : PubMed/NCBI
43	Chen C, Wei M, Wang C, Sun D, Liu P, Zhong X, He Q and Yu W: The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer. Gene. 754:1448512020. View Article : Google Scholar : PubMed/NCBI